Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2019

Jan 3, 2019

34975_dirs_2019-01-03_d13bf74f-ed75-4b0a-8178-a5ba8cde4b4b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-01-01

Reporting Person: Unninayar Kamalam (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-01-01 Common Stock F 1603 $3.18 Disposed 16866 Direct

Footnotes

F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019.

F2: Includes (a) a deferred stock award of 13,852 restricted stock units which vest in three equal annual installments on January 1, 2020, 2021 and 2022; and (b) 3,014 shares of common stock held by the Reporting Person.